Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathogenesis of NASH
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1575-1575
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra, Gianluca Svegliati‐Baroni
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 280-295
Closed Access | Times Cited: 687
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouriès, Paola Brescia, Alessandra Silvestri, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 6, pp. 1216-1228
Open Access | Times Cited: 502
Direct effects of thyroid hormones on hepatic lipid metabolism
Rohit A. Sinha, Brijesh Kumar Singh, Paul M. Yen
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 5, pp. 259-269
Open Access | Times Cited: 496
Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
Vivek Singh, Saba Ubaid
Inflammation (2020) Vol. 43, Iss. 5, pp. 1589-1598
Closed Access | Times Cited: 308
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Vignan Manne, Priya Handa, Kris V. Kowdley
Clinics in Liver Disease (2017) Vol. 22, Iss. 1, pp. 23-37
Closed Access | Times Cited: 296
Emerging roles of SIRT1 in fatty liver diseases
Ren‐Bo Ding, Jiaolin Bao, Chu‐Xia Deng
International Journal of Biological Sciences (2017) Vol. 13, Iss. 7, pp. 852-867
Open Access | Times Cited: 295
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 5, pp. 471-483
Open Access | Times Cited: 288
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Gianluca Svegliati‐Baroni, I. Pierantonelli, Pierangelo Torquato, et al.
Free Radical Biology and Medicine (2019) Vol. 144, pp. 293-309
Closed Access | Times Cited: 193
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6571-6592
Open Access | Times Cited: 182
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Alessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2759-2759
Open Access | Times Cited: 164
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 5, pp. 1012-1021
Closed Access | Times Cited: 159
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutiérrez‐Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 143
Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)
Patrizia Burra, Debora Bizzaro, Anna Gonta, et al.
Liver International (2021) Vol. 41, Iss. 8, pp. 1713-1733
Open Access | Times Cited: 113
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 883-883
Open Access | Times Cited: 60
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Paloma Sangro, Manuel de la Torre‐Aláez, Bruno Sangro, et al.
Journal of Physiology and Biochemistry (2023) Vol. 79, Iss. 4, pp. 869-879
Open Access | Times Cited: 60
Intestinal microbiota and nonalcoholic steatohepatitis
Katharina Brandl, Bernd Schnabl
Current Opinion in Gastroenterology (2017) Vol. 33, Iss. 3, pp. 128-133
Open Access | Times Cited: 161
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
Nahúm Méndez‐Sánchez, Vania Cruz-Ramón, Oscar Ramírez-Pérez, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 2034-2034
Open Access | Times Cited: 140
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 329-341
Open Access | Times Cited: 138
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
Anil Kumar, Arti Singh
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 132
Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
Xueke Zhao, Lei Yu, Mingliang Cheng, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 107
Pathogenesis of NASH: the Impact of Multiple Pathways
Mazen Noureddin, Arun J. Sanyal
Current Hepatology Reports (2018) Vol. 17, Iss. 4, pp. 350-360
Open Access | Times Cited: 107
Loss of hepatic Mboat7 leads to liver fibrosis
Veera Raghavan Thangapandi, Oskar Knittelfelder, Mario Brosch, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 940-950
Open Access | Times Cited: 100
Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic TargetsReviewing Editors:Markus Bachschmid, Dylan Burger, Vittorio Calabrese, Amadou Camara, Lukas Kubala, Giuseppe Poli, and Chandan K. Sen
Susana Rovira‐Llopis, Nadezda Apostolova, Celia Bañuls, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 8, pp. 749-791
Open Access | Times Cited: 98
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Youngmi Jung
Cells (2019) Vol. 8, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 97
Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice
Junli Zhang, Haiming Zhang, Xiaoling Deng, et al.
Life Sciences (2017) Vol. 192, pp. 46-54
Closed Access | Times Cited: 94
Page 1 - Next Page

Scroll to top